Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • NF-κB
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

laquinimod

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Activity
Laquinimod
T6561248281-84-7
Laquinimod (LAQ) is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy.
  • $37
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Laquinimod sodium
T61607248282-07-7
Laquinimod (ABR-215062) sodium is a carboxamide derivative administered orally that serves as a powerful immunomodulator, designed to prevent inflammation and neurodegeneration within the central nervous system. This compound effectively diminishes the activation of astrocytic NF-κB, offering protection against Cuprizone-induced demyelination. It shows promise for the treatment of both relapsing-remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS), in addition to its potential applications in the study of neurodegenerative diseases [1] [2] [3] [4].
  • $2,140
1-2 weeks
Size
QTY